Do anti‐Aβ monoclonal antibodies lower brain plaques in Alzheimer patients through microglia activation?
Alzheimer's & Dementia · 2024-03 · 20 (3) · 2289-2290
DOI: 10.1002/alz.13684 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alzheimer's & Dementia, online erschienen am 15.01.2024. Verfasst von Nunzio Pomara und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nathan S Kline Institute for Psychiatric Research, Geriatric Psychiatry Division, Orangeburg, New York, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Do anti-Aβ monoclonal antibodies lower brain plaques in Alzheimer patients through microglia activation?Alzheimer'
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nathan S Kline Institute for Psychiatric Research, Geriatric Psychiatry Division, Orangeburg, New York, USA.
- Research & Development Department, Chiesi Farmaceutici, Parma, Italy.
Zitieren
APA
Pomara, N., & Imbimbo, B. P. (2024). Do anti‐Aβ monoclonal antibodies lower brain plaques in Alzheimer patients through microglia activation?. Alzheimer's & Dementia, 20(3), 2289-2290. https://doi.org/10.1002/alz.13684
Vancouver
Pomara N, Imbimbo BP. Do anti‐Aβ monoclonal antibodies lower brain plaques in Alzheimer patients through microglia activation?. Alzheimer's & Dementia. 2024;20(3):2289-2290. doi:10.1002/alz.13684
BibTeX
@article{Pomara2024,
author = {Pomara, Nunzio and Imbimbo, Bruno Pietro},
title = {Do anti‐Aβ monoclonal antibodies lower brain plaques in Alzheimer patients through microglia activation?},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {3},
pages = {2289--2290},
doi = {10.1002/alz.13684}
}
EUVIMED